Patent assignee · FR · COMPANY

Laboratories UPSA

33Patents
0Active
33Granted
35Portfolio score

Filing activity: Mar 1, 1988 → Apr 4, 2002

Most-cited patents

PatentTitleAreaCited byStatus
US5142098A Methylidenemalonate esters derived from esters of 9,10-endoethano-9,10-dihydroanthracane-11,11-dicarboxylic acid Chemistry; Metallurgy 67 Expired
US4931584A Process for the preparation of monoesters or diesters of-9,10-endoethano-9,10-dihydroanthracene-11,11-dicarboxylic acid and for the preparation of symmetrical or asymmetrical methylidenemalonates Chemistry; Metallurgy 59 Expired
US5459132A N6-[(Imidazo[1,2-a]pyridin-3-yl)ethyl]adenosines, their 5'-uronamide analogues and pharmaceutical compositions Chemistry; Metallurgy 56 Expired
US5128359A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation Chemistry; Metallurgy 33 Expired
US5021443A Noval benzimidazole and azabenzimiazole derivatives which are thromboxane receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present Chemistry; Metallurgy 31 Expired
US5231094A Triazolopyrimidines which are angiotensin II receptor antagonists and pharmaceutical compositions in which they are present Chemistry; Metallurgy 25 Expired
US5192781A Thiazole derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present Chemistry; Metallurgy 22 Expired
US5723485A 1,2-Diarylindole derivatives, processes for their preparation and their uses in therapeutics Chemistry; Metallurgy 15 Expired
US6015797A Adenosinergic agonist containing pharmaceutical composition with analgesic activity Human Necessities 15 Expired
US5480652A Effervescent pharmaceutical composition containing ibuprofen and its method of preparation Human Necessities 14 Expired
US5387747A Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present Chemistry; Metallurgy 14 Expired
US5807873A Diarylmethylidenefuran derivatives and their uses in therapeutics Chemistry; Metallurgy 13 Expired
US5124336A Azabenzimidazole derivatives which are thromboxane receptor antagonists Chemistry; Metallurgy 13 Expired
US5389632A Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists Chemistry; Metallurgy 12 Expired
US5219839A Adenosine derivatives, their methods of preparation and pharmaceutical compositions in which they are present Chemistry; Metallurgy 11 Expired
US5358950A Triazolopyrimidine derivatives which are angiotensin II receptor antagonists Chemistry; Metallurgy 10 Expired
US6593331B2 Method for treatment of pain Human Necessities 10 Expired
US5686460A Carbocyclic diarylmethylene derivatives, processes for their preparation and their uses in therapeutics Chemistry; Metallurgy 9 Expired
US5217973A Triazolopyrimidine derivatives which are angiotensin II receptor antagonists processes for preparing them and pharmaceutical compositions containing them Human Necessities 9 Expired
US5859036A 3,4-diarylthiazolin-2-one or -2-thione derivatives, their methods of preparation and their uses in their methods of preparation and their uses in therapeutics Chemistry; Metallurgy 8 Expired
US5437874A Pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredients Human Necessities 8 Expired
US5200408A Analgesic .alpha.-amino-N-pyridylbenzenepropanamide derivatives and pharmaceutical compositions containing them Chemistry; Metallurgy 8 Expired
US5567437A Effervescent pharmaceutical composition containing ibuprofen and its method of preparation Human Necessities 8 Expired
US5866596A 3,4-diaryloxazolone derivatives, their methods of preparation and their uses in therapeutics Chemistry; Metallurgy 6 Expired
US5229505A N.sup.6 -[3-(1-substituted)indolylethyl] adenosine 5'-carboxamides and their pharmaceutical compositions Emerging Cross-Sectional Technologies 6 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.